Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Hair loss needs more research for better treatments.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Thyroid receptor β can help develop new drugs to treat hair loss.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Minoxidil and finasteride effectively treat hair loss.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Testosterone may slow down wound healing and increase inflammation.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.